Table 1.

Demographic characteristics of randomized patients.

	EGCG	EGCG + Clomiphene	EGCG + Letrozole	All	p-Value for Comparison among Three Groups
Age (years)	16 29.6 ± 6.3 28.5 (24.0 to 35.5)	11 27.2 ± 6.6 28.0 (19.0 to 34.0)	12 29.3 ± 6.3 27.0 (25.0 to 34.5)	39 28.8 ± 6.3 28.0 (24.0 to 34.0)	0.675
BMI (kg/m2)	16 26.1 ± 6.8 24.3 (22.1 to 29.3)	11 27.4 ± 5.7 28.3 (22.4 to 31.0)	12 28.4 ± 9.5 25.0 (22.6 to 30.9)	39 27.2 ± 7.3 25.0 (22.2 to 30.6)	0.709
Hip circumference (cm)	16 112.9 ± 35.1 104.0 (95.5 to 112.5)	10 103.6 ± 18.1 108.2 (90.0 to 116.0)	12 106.2 ± 19.4 105.3 (92.0 to 120.0)	38 108.4 ± 26.6 104.8 (94.0 to 116.0)	0.946
Waist circumference (cm)	16 90.7 ± 27.0 80.5 (75.5 to 99.0)	10 86.0 ± 13.4 89.8 (75.0 to 97.0)	12 88.6 ± 21.0 88.2 (71.6 to 97.3)	38 88.8 ± 21.8 84.1 (75.0 to 97.0)	0.991
Ethnicity					1.000
Hispanic or Latino	2/16 (12.5%)	2/11 (18.2%)	2/12 (16.7%)	6/39 (15.4%)
Non-Hispanic	14/16 (87.5%)	9/11 (81.8%)	10/12 (83.3%)	33/39 (84.6%)
Race					0.763
White	11/16 (68.8%)	6/11 (54.5%)	6/12 (50.0%)	23/39 (59.0%)
Black	2/16 (12.5%)	2/11 (18.2%)	1/12 (8.3%)	5/39 (12.8%)
Asian	2/16 (12.5%)	2/11 (18.2%)	4/12 (33.3%)	8/39 (20.5%)
Native Hawaiian/Pacific Islander	1/16 (6.3%)	0/11 (0.0%)	0/12 (0.0%)	1/39 (2.6%)
I prefer not to answer	0/16 (0.0%)	1/11 (9.1%)	1/12 (8.3%)	2/39 (5.1%)
Have ever been diagnosed with fibroids	3/16 (18.8%)	2/11 (18.2%)	1/12 (8.3%)	6/39 (15.4%)	0.742
Have had endometriosis	1/15 (6.7%)	0/10 (0.0%)	0/11 (0.0%)	1/36 (2.8%)	1.000
History of smoking					0.949
Never	13/16 (81.3%)	9/10 (90.0%)	9/11 (81.8%)	31/37 (83.8%)
Current	2/16 (12.5%)	0/10 (0.0%)	1/11 (9.1%)	3/37 (8.1%)
Former	1/16 (6.3%)	1/10 (10.0%)	1/11 (9.1%)	3/37 (8.1%)
History of alcohol use					0.642
Never	1/16 (6.3%)	1/11 (9.1%)	3/12 (25.0%)	5/39 (12.8%)
Current	14/16 (87.5%)	9/11 (81.8%)	8/12 (66.7%)	31/39 (79.5%)

EGCG: Epigallocatechin gallate; BMI: Body Mass Index.